anmelden
BX Swiss TOP 30 CHF
1.513,33
PKT
+2,95
PKT
+0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.02.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 08.02.12 | UBS buy | Nomura | |
| 08.02.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 08.02.12 | UBS overweight | Morgan Stanley | |
| 08.02.12 | UBS verkaufen | Independent Research GmbH | |
| 07.02.12 | UBS neutral | WestLB AG | |
| 07.02.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 07.02.12 | UBS neutral | Sarasin Research | |
| 07.02.12 | Novartis underperform | Banc of America Securities-Merrill Lynch | |
| 07.02.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 07.02.12 | Zurich Insurance buy | Société Générale Group S.A. (SG) | |
| 07.02.12 | Julius Bär buy | Sarasin Research | |
| 07.02.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 06.02.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 06.02.12 | ABB (Asea Brown Boveri) neutral | UBS AG | |
| 06.02.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 03.02.12 | Roche outperform | Exane-BNP Paribas SA | |
| 03.02.12 | Holcim hold | Deutsche Bank AG | |
| 03.02.12 | Roche overweight | Barclays Capital | |
| 03.02.12 | Givaudan neutral | UBS AG | |
| 03.02.12 | Logitech neutral | Sarasin Research | |
| 02.02.12 | Roche neutral | Nomura | |
| 01.02.12 | UBS neutral | Banc of America Securities-Merrill Lynch | |
| 01.02.12 | UBS buy | Banc of America Securities-Merrill Lynch | |
| 01.02.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 01.02.12 | Holcim neutral | J.P. Morgan Cazenove | |
| 01.02.12 | Holcim neutral | J.P. Morgan Cazenove | |
| 01.02.12 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 01.02.12 | UBS underperform | Cheuvreux SA | |
| 01.02.12 | Roche buy | Sarasin Research | |
| 01.02.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 31.01.12 | Holcim sell | Goldman Sachs Group Inc. | |
| 31.01.12 | Roche overweight | J.P. Morgan Cazenove | |
| 31.01.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 31.01.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 31.01.12 | Nestlé kaufen | Hamburger Sparkasse AG (Haspa) | |
| 31.01.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
| 31.01.12 | Novartis neutral | Goldman Sachs Group Inc. | |
| 31.01.12 | Nestlé outperform | Cheuvreux SA | |
| 31.01.12 | Zurich Insurance buy | Nomura |
